SALVAGENIX Trademark

Trademark Overview

On Monday, September 15, 2025, a trademark application was filed for SALVAGENIX with the United States Patent and Trademark Office. The USPTO has given the SALVAGENIX trademark a serial number of 99393012. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 15, 2025. This trademark is owned by Salvagenix Inc.. The SALVAGENIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; Veterinary preparations for digoxin, digitalis or other cardio-active glycoside toxicity; Pharmaceutical preparations for the treatment of pre-eclampsia; Chemical reagents for medical or veterinary use; Pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; Chemical preparations for pharmaceutical or medical purposes, namely, for medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; Veterinary preparations for the treatment of pre-eclampsia
salvagenix

General Information

Serial Number99393012
Word MarkSALVAGENIX
Filing DateMonday, September 15, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of a heart with the left side being purple and the right side being red connecting in the middle of the heart with a heartbeat line, the word SALVAGENIX underneath in purple.
Goods and ServicesPharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; Veterinary preparations for digoxin, digitalis or other cardio-active glycoside toxicity; Pharmaceutical preparations for the treatment of pre-eclampsia; Chemical reagents for medical or veterinary use; Pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; Chemical preparations for pharmaceutical or medical purposes, namely, for medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; Veterinary preparations for the treatment of pre-eclampsia
Indication of Colors claimedThe color(s) purple and red is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 15, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSalvagenix Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808-1674

Trademark Events

Event DateEvent Description
Monday, September 15, 2025NEW APPLICATION ENTERED
Monday, September 15, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

salvagenix treatment preparations pharmaceutical toxicity eclampsia active glycoside cardio digoxin digitalis